Geode Capital Management
TNGX icon

Geode Capital Management’s Tango Therapeutics TNGX Stock Holding History

Geode Capital Management’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$101M Buy
4,039,215
+296,424
+8% +$7.72M 0.01% 1149
2026
Q2 		$117M Buy
3,742,791
+1,067,014
+40% +$26.4M 0.01% 1088
2026
Q1 		$56M Buy
2,675,777
+122,121
+5% +$1.7M ﹤0.01% 1432
2025
Q4 		$22.6M Buy
2,553,656
+670,879
+36% +$5.78M ﹤0.01% 1936
2025
Q3 		$15.8M Buy
1,882,777
+113,864
+6% +$771K ﹤0.01% 2128
2025
Q2 		$9.06M Buy
1,768,913
+385,476
+28% +$953K ﹤0.01% 2426
2025
Q1 		$1.9M Sell
1,383,437
-3,012
-0.2% -$7.4K ﹤0.01% 3055
2024
Q4 		$4.29M Buy
1,386,449
+18,187
+1% +$84.4K ﹤0.01% 2815
2024
Q3 		$10.5M Buy
1,368,262
+142,710
+12% +$1.36M ﹤0.01% 2347
2024
Q2 		$10.5M Buy
1,225,552
+92,017
+8% +$711K ﹤0.01% 2293
2024
Q1 		$9M Buy
1,133,535
+36,433
+3% +$391K ﹤0.01% 2387
2023
Q4 		$10.9M Buy
1,097,102
+62,108
+6% +$539K ﹤0.01% 2297
2023
Q3 		$11.7M Buy
1,034,994
+96,157
+10% +$586K ﹤0.01% 2165
2023
Q2 		$3.12M Buy
938,837
+51,966
+6% +$187K ﹤0.01% 2950
2023
Q1 		$3.5M Buy
886,871
+34,503
+4% +$200K ﹤0.01% 2790
2022
Q4 		$6.18M Buy
852,368
+12,605
+2% +$88.7K ﹤0.01% 2547
2022
Q3 		$3.04M Sell
839,763
-150,737
-15% -$644K ﹤0.01% 2935
2022
Q2 		$4.49M Buy
990,500
+397,158
+67% +$2.4M ﹤0.01% 2756
2022
Q1 		$4.5M Buy
593,342
+6,165
+1% +$53.4K ﹤0.01% 2854
2021
Q4 		$6.42M Buy
587,177
+158,542
+37% +$1.91M ﹤0.01% 2746
2021
Q3 		$5.54M Buy
428,635
+414,626
+2,960% +$4.97M ﹤0.01% 2847
2021
Q2 		$159K Buy
+14,009
New +$157K ﹤0.01% 4423

Other funds holding TNGX

Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Jefferies Financial Group
Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Mass General Brigham
Mass General Brigham Somerville, Massachusetts $456M AUM 27.51% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Geode Capital Management's TNGX Position: Q3 2026 in Review

Geode Capital Management increased its Tango Therapeutics (TNGX) stake by 7.9% in Q3 2026, buying an estimated $7.72M and bringing the position to 4,039,215 shares worth $101M. The position accounts for 0.01% of the portfolio, ranked #1149.

Geode Capital Management first reported a position in TNGX in Q2 2021 and has held it in 22 quarters since. The position peaked at $117M in Q2 2026. 74 funds tracked by Wall St. Rank hold TNGX as of Q3 2026.

  • Geode Capital Management held 4,039,215 shares of Tango Therapeutics worth $101M as of Q3 2026.
  • Geode Capital Management bought 296,424 Tango Therapeutics shares in Q3 2026, an estimated $7.72M.
  • Tango Therapeutics made up 0.01% of Geode Capital Management's portfolio in Q3 2026, its #1149 holding.
  • Geode Capital Management first reported a position in Tango Therapeutics in Q2 2021 and has held it in 22 quarters since.
  • Geode Capital Management's Tango Therapeutics position peaked at $117M in Q2 2026.
  • 74 funds tracked by Wall St. Rank held Tango Therapeutics as of Q3 2026.

Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.